DIAGA-PHARMA SL
Company details
- Active NIF/CIF: B85248581
-
-
-
-
Address: Avenida del General Perón, 1, 28020 Madrid, Madrid, España See in map
-
-
Featured products:
More information on DIAGA-PHARMA SL
-
29/09/2010 | BORME act no.: 704195 | Register: MADRIDDepósito de cuentas anuales (Septiembre de 2010)
-
16/12/2009 | BORME act no.: 1019151 | Register: MADRIDDepósito de cuentas anuales (Noviembre de 2009)
-
16/09/2008 | BORME act no.: 554706 | Register: MADRIDDepósito de cuentas anuales (Agosto de 2008)
-
04/12/2007 | BORME act no.: 603845 | Register: MADRIDConstitución
-
04/12/2007 | BORME act no.: 603845 | Register: MADRIDDeclaración de unipersonalidad
-
04/12/2007 | BORME act no.: 603845 | Register: MADRIDNombramientos
Other information
The CIF assigned to DIAGA-PHARMA SL is B85248581, while its current business status is active. The company operates in the economic sector identified by the CNAE 7490 - Otras actividades profesionales, científicas y técnicas n.c.o.p.. In addition, its activity corresponds to the SIC classification -.
The template of DIAGA-PHARMA SL includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. DIAGA-PHARMA SL is registered in the Mercantile Registry of Madrid and accumulates a total of 2 registration charges. The most recent announcement in Borme was published on 29/09/2010, while its last deposit of ordinary annual accounts is related to the - exercise.
If you want to obtain contact information for DIAGA-PHARMA SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about DIAGA-PHARMA SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about DIAGA-PHARMA SL comes from official data sources and is automatically updated every day.
Do you want to know more about DIAGA-PHARMA SL??
Find out more about this company by consulting these reports: